Peter van de Sande
Chief Executive Officer at SynAffix BV
Peter van de Sande active positions
| Companies | Position | Start | End |
|---|---|---|---|
SynAffix BV
 SynAffix BV BiotechnologyHealth Technology SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands. | Director/Board Member | - | - |
| Chief Executive Officer | - | - |
Career history of Peter van de Sande
Former positions of Peter van de Sande
| Companies | Position | Start | End |
|---|---|---|---|
Corob Oy
 Corob Oy Industrial SpecialtiesProcess Industries Corob Oy supplies color tinting systems. It offers complete tinting solutions: CPSCOLOR TM colorants (liquid pigments), COROB TM dispensing and mixing/shaking equipment, software, color marketing tools, customer support and service. The firm serves paint manufacturers, retail chains, leather and plastics producers. The company was founded in 2000 and is headquartered in Pori, Finland. | Sales & Marketing | - | - |
Training of Peter van de Sande
| Technische Universiteit Eindhoven | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
| The University of Sydney | Graduate Degree |
Statistics
International
| Netherlands | 3 |
| United States | 2 |
| Australia | 2 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
SynAffix BV
SynAffix BV BiotechnologyHealth Technology SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands. | Health Technology |
Corob Oy
Corob Oy Industrial SpecialtiesProcess Industries Corob Oy supplies color tinting systems. It offers complete tinting solutions: CPSCOLOR TM colorants (liquid pigments), COROB TM dispensing and mixing/shaking equipment, software, color marketing tools, customer support and service. The firm serves paint manufacturers, retail chains, leather and plastics producers. The company was founded in 2000 and is headquartered in Pori, Finland. | Process Industries |
- Stock Market
- Insiders
- Peter van de Sande
- Experience
